Significance of stromal decorin expression during the progression of breast cancer
- 17 September 2012
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 28 (6) , 2003-2008
Abstract
Decorin, a small leucine-rich proteoglycan and important component of the extracellular matrix (ECM), is a natural anticancer agent that modulates several receptors involved in cell growth and survival. Reductions in decorin expression may weaken the ECM and enhance the effectiveness of these receptors and may, consequently, lead to tumor spreading. To determine the contribution of stromal decorin regulation in the development of breast cancer and in tumor invasiveness, immunohistochemistry was used to examine the expression of stromal decorin in 120 breast cancer tissue samples. In patients with invasive breast carcinoma (IBC), stromal decorin expression was highest in normal gland tissue, lower in in situ components and the lowest in invasive components. Stromal decorin expression adjacent to malignant cells in IBC tumors was also significantly weaker compared to that in pure ductal carcinoma in situ (DCIS). These findings indicate that there is a striking difference in the stromal decorin expression around normal glands and around DCIS or IBC tumors. Reduced levels of decorin were associated with more aggressive disease; this finding was consistent with the view that reduced decorin expression may facilitate tumorigenesis, tumor invasion and/or tumor growth. Given these and other reported findings, evaluating stromal decorin expression may be useful in assessing prognosis and malignant potential; therefore, a large-scale study of decorin expression is warranted.Keywords
This publication has 23 references indexed in Scilit:
- Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptorJournal of Endocrinology, 2011
- Expression of Decorin in Esophageal Cancer in Relation to the Expression of Three Isoforms of Transforming Growth Factor-Beta (TGF-β1, -β2, and -β3) and Matrix Metalloproteinase-2 ActivityCancer Investigation, 2009
- Tumor microenvironment: Modulation by decorin and related molecules harboring leucine‐rich tandem motifsInternational Journal of Cancer, 2008
- An Antimetastatic Role for Decorin in Breast CancerThe American Journal of Pathology, 2008
- Decorin Suppresses Bone Metastasis in a Breast Cancer Cell LineOncology, 2008
- Decorin-transforming Growth Factor-β Interaction Regulates Matrix Organization and Mechanical Characteristics of Three-dimensional Collagen MatricesJournal of Biological Chemistry, 2007
- Ductal Carcinoma in Situ of the BreastNew England Journal of Medicine, 2004
- The role of decorin in collagen fibrillogenesis and skin homeostasisGlycoconjugate Journal, 2002
- MATRIX PROTEOGLYCANS: From Molecular Design to Cellular FunctionAnnual Review of Biochemistry, 1998
- Negative regulation of transforming growth factor-β by the proteoglycan decorinNature, 1990